Product Information
AUSTEDO XR TITR(12-18-24-30 MG) is a brand product labeled by Teva Neuroscience, Inc., priced at $249.3230 per EA under NDC 68546047729. Its NADAC has been published 32 times since Nov 19, 2025.
Manufacturer
Teva Neuroscience, Inc.NDC
68546047729
Classification
Brand
Dosage Form
KIT
Last Updated
1/1/2026
Approval Type
New Drug (NDA)
FDA Application
NDA216354On Market Since
7/1/2024
Price Statistics
The NADAC for AUSTEDO XR TITR(12-18-24-30 MG) has been published 32 times since Nov 19, 2025, and over the history we have for it it has risen 5.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $249.3230 per EA |
|---|---|
| All-time high | $249.3230 (Jun 24, 2026) |
| All-time low | $236.3251 (Dec 17, 2025) |
| 52-week high | $249.3230 |
| 52-week low | $236.3251 |
| Median price | $249.3230 |
| Average price | $246.4905 |
| Largest weekly change | +5.5% (Jan 7, 2026) |
| Weeks tracked | 32 |
| Tracking since | Nov 19, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the deutetrabenazine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AUSTEDO XR TITR(12-18-24-30 MG)?
The current National Average Drug Acquisition Cost (NADAC) for AUSTEDO XR TITR(12-18-24-30 MG), manufactured by Teva Neuroscience, Inc., is $249.3230 per EA (NDC 68546047729), effective Jun 24, 2026.
How has the price of AUSTEDO XR TITR(12-18-24-30 MG) changed over time?
Over the history we have for it, the NADAC for AUSTEDO XR TITR(12-18-24-30 MG) has risen 5.5%. It has been tracked across 32 weekly CMS publications since Nov 19, 2025.
What are the highest and lowest recorded NADAC prices for AUSTEDO XR TITR(12-18-24-30 MG)?
Since Nov 19, 2025, the NADAC for AUSTEDO XR TITR(12-18-24-30 MG) has ranged from a low of $236.3251 (Dec 17, 2025) to a high of $249.3230 (Jun 24, 2026), with a median of $249.3230 per EA.
Are there cheaper alternatives to AUSTEDO XR TITR(12-18-24-30 MG)?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AUSTEDO XR TITR(12-18-24-30 MG), so no direct lower-cost alternative is listed.
Who manufactures AUSTEDO XR TITR(12-18-24-30 MG)?
AUSTEDO XR TITR(12-18-24-30 MG) (NDC 68546047729) is labeled by Teva Neuroscience, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification